Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Warmuth Markus sold 9,500 Monte Rosa Therapeutics, Inc. shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 17, 2026

On Jul 16, 2026, Warmuth Markus (Director, President & CEO) sold 9,500 Monte Rosa Therapeutics, Inc. shares at US$23.18 for US$220K, leaving 585,038 shares. Filed Jul 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$23.18
Value
US$220K
Holding after
585,038 shares
Trading plan
No
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Common StockSale9,500US$23.18585,038Direct

Source

View original at SEC

Related